Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Deficit) (Tables)

v3.7.0.1
Stockholders' Equity (Deficit) (Tables)
3 Months Ended
Mar. 31, 2017
Equity [Abstract]  
Schedule of Stock-based Compensation Expense

The Company’s stock-based compensation expense recognized for the periods presented was as follows:

 

     Three Months Ended
March 31,
 
     2017      2016  

Stock-based compensation expense by type of award:

     

Restricted stock

   $ 76      $ 20  

Stock options

     49        22  
  

 

 

    

 

 

 

Total

   $ 125      $ 42  
  

 

 

    

 

 

 

Stock-based compensation expense by operating expense grouping:

     

Sales and marketing

   $ 39      $ 24  

Research and development

     12        1  

General and administrative

     74        17  
  

 

 

    

 

 

 

Total

   $ 125      $ 42  
  

 

 

    

 

 

 
Schedule of Restricted Stock Activity

Restricted stock activity for the periods presented was as follows:

 

     Shares      Weighted
Average Grant
Date Fair Value
 

Unvested at December 31, 2016

     208,886      $ 4.80  

Granted

     1,500      $ 7.67  

Forfeited

     (12,000    $ 7.50  

Vested

     (22,831    $ 4.08  
  

 

 

    

Unvested at March 31, 2017

     175,555      $ 4.72  
  

 

 

    
Schedule of Stock Option Activity

The Company’s stock option activity for the period presented was as follows:

 

            Weighted-Average  
     Options      Exercise
Price
     Remaining
Contractual
Term
     Aggregate
Intrinsic
Value
 

Outstanding at December 31, 2016

     680,434      $ 2.27        8.49 years      $ 3,031  

Options Granted

     —        $ —          

Options Exercised

     —        $ —          

Options Forfeited / Cancelled

     (24,318    $ 4.17        
  

 

 

          

Outstanding at March 31, 2017

     656,116      $ 2.23        8.40 years      $ 6,555  
  

 

 

          

Exercisable at March 31, 2017

     313,830